Sleep and interleukin 6 as modifiers of cognitive stimulation therapy response in schizophrenia [0.03%]
睡眠和白细胞介素6作为认知刺激疗法治疗精神分裂症的调节因子
Yizhen Wang,Xiaoling Li,Junying Feng et al.
Yizhen Wang et al.
Comment on "Discriminative ability of left atrial strain in heart failure with mildly reduced ejection fraction" [0.03%]
关于“射血分数轻度降低的心力衰竭中左心房应变的鉴别能力”的评论
Zhi-Yuan Xu,Zhong Qi
Zhi-Yuan Xu
Reply on "Interaction of ALDH2 and ALDH1A single-nucleotide polymorphisms with alcohol consumption and impact on osteoporosis risk" [0.03%]
ALDH2和ALDH1A单核苷酸多态性与饮酒对骨质疏松症风险影响的交互作用研究答复
Chin-Yuan Yii,Jing-Yang Huang,Su-Boon Yong et al.
Chin-Yuan Yii et al.
Response to comment on "Association between anticholinergic drug use and hepatic encephalopathy risk among patients with cirrhosis" [0.03%]
关于抗胆碱药使用与肝硬化患者肝性脑病风险关联的评论回复
Hsin-Ni Shih,Chung-Hsuen Wu,Yuan-Wen Lee et al.
Hsin-Ni Shih et al.
Overlooked explanatory pathways and overstated conclusions in the VA-14 vs. S-14 non-inferiority trial [0.03%]
VA14-t与S-14非劣性试验中的被忽视的解释途径及过度解读结论
Chenxi Yang,Jingyi Wu,Chuanlong Zhou
Chenxi Yang
Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort" [0.03%]
评论:“胰腺导管腺癌改良FOLFIRINOX方案初始相对剂量强度的优化:一项多中心回顾性队列研究”
M Ganga Raju,Praveen Kumar Annagowni,N V L Suvarchala Reddy V
M Ganga Raju
Reply to "Comment on 'Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan'" [0.03%]
对“台湾原发性胆汁性肝硬化患者结肠息肉和结直肠癌风险的队列研究”的评论的回复
Pei-Tzu Chen,Hsuan-Wei Chen
Pei-Tzu Chen
Acute cerebral infarction following endoscopic endonasal pituitary adenoma resection: A case report [0.03%]
内镜经鼻垂体腺瘤切除术后急性脑梗死的病例报告
Peng-Fei Wang,Xiao-Yang Zhang,Xiao-Yan Wang et al.
Peng-Fei Wang et al.